Asston Pharmaceuticals Limited (BOM:544445)

Asston Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Asston Pharmaceuticals had annual revenue of 315.84M INR with 26.14% growth. Asston Pharmaceuticals had revenue of 154.16M in the half year ending September 30, 2025.

• Revenue: 315.84M
• Revenue Growth: +26.14%
• P/S Ratio: 2.21
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 698.06M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	315.84M	65.45M	26.14%
Mar 31, 2025	250.39M	94.53M	60.65%
Mar 31, 2024	155.86M	90.48M	138.39%
Mar 31, 2023	65.38M	-30.61M	-31.89%
Mar 31, 2022	95.99M	15.64M	19.47%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 15, 2026

Data Sources Report a data error